The Hebrew University of Jerusalem will be offering a course in medical cannabis. The course is designed to educate medical professionals about new cannabinoid treatments, practices, and the latest research.
The director of the university's medical cannabis research center said that the importance of medical cannabis education is undisputed. It is more important than ever for doctors to understand the benefits and drawbacks of cannabis as it is becoming legalized in more and more countries. The expertise and knowledge at the university are reflected in our course. The knowledge to treat and advise with confidence will be gained from learning from our leading cannabis researchers.
The Hebrew University of Jerusalem is going to offer a medical cannabis course.
Professor Raphael Mechoulam is known as the "Father of Cannabis Research" for his significant discoveries in the field over the past five decades. The professor at the Hadassah Medical Center is one of the MCCR experts.
According to the university, patients often seek education about medical marijuana, but their doctors don't take advantage of the treatment opportunities that come with it. Many healthcare professionals are learning more about medical cannabis treatments. The virtual medical cannabis series was created to help address the stigma associated with cannabis in the medical field and to help educate the public. There is a need to educate physicians and other health professionals as more and more countries allow the use of medical cannabis.
The course aims to educate health professionals about the therapeutic role of medical cannabis in patient health. There are many uses for cannabis, from treating nausea and vomiting to treating chronic pain and multiple sclerosis.
Marijuana is used by patients to treat a variety of conditions.
Yissum, Hebrew University's technology transfer company, created and produced the online medical cannabis course. The virtual course will be made available to a global audience. The aim of the course is to provide a thorough education for medical professionals about the therapeutic use of cannabis. The course is discussed in a video on the internet.
Yissum is a bridge between cutting-edge academic research and a global community of entrepreneurs. The company wants to benefit society by converting innovative technologies into commercial solutions that address the most urgent global challenges.
The benefits of cannabis treatments will be offered to patients and doctors throughout the course. Yissum is proud of this project and is looking forward to the course's inevitable growth.
Detroit awards first 33 recreational marijuana retail licenses after court ruling
After four years after Detroit voters overwhelmingly approved recreational marijuana sales, the city on Thursday awarded its first batches of licenses.
The first 33 recipients of recreational adult-use marijuana retail licenses were announced by a group of people.
The announcement was made after a federal court ruling against the city's marijuana law. The first attempt at how to award recreational marijuana licenses to "legacy Detroiters" in 2020 was likely unconstitutional. The city has re-written the law to be inclusive, but still prioritize equity applicants in order to give Detroiters a chance in the marijuana industry.
There is a tax on top of the sales tax for marijuana. There will be no more taxes beyond that.
Kim James, director of the city's Marijuana Ventures & Entrepreneurship, expects the revenue sharing from marijuana to be millions of dollars for the city. Michigan's recreational cannabis revenue is expected to hit a new high of over $1 billion this year and is expected to reach $3 billion in revenue by the year's end.
Christmas came early for cannabis Detroiters, according to Bettison.
Bettison thanked Tate for making sure the process was fair and the team and several others for overcoming several core challenges. Marijuana interest has the potential to generate wealth for our city as well as for those who participate.
A primary resident of Detroit who has been disproportionately impacted by marijuana enforcement where 20% of residents live below the federal poverty level and the marijuana conviction rate is higher than the state median is an equity application. An equity advocate is someone who owns at least 51% of the business.
The city got 90 applications. The city is giving 13 non-equity retail licenses. The city has 33 equity license applications.
Four equity microbusiness applications were not awarded.
There were no non-equity applicants for consumption lounges.
It has been a fight to make sure the lucrative industry was possible for those who are disproportionately impacted, said Tate, who led the initiative over the last few years.
Tate said that he was thankful for the wisdom of Judge Friedman not allowing a temporary restraining order to be issued.
The journey to this point has been very difficult. There's criticism from people who say that you're trying to make something that can't be perfect. We fight because we want to make sure that this industry doesn't have a glass ceiling for those who have been through the same thing.
New York legalized adult-use cannabis in March of 2021.
Many New Yorkers have lost patience and have chosen to participate in the grey market.
Cannabis and cannabis-derived products are being cultivated, grown, processed, produced, and sold without any regulatory oversight contemplated by New York's Marijuana Regulation and Tax Act. Many people involved in the gray market may not be aware of the legal implications of their involvement in the cannabis industry.
Each phase of the cannabis supply chain needs a state license. The entire cannabis program was intended to be tightly regulated to ensure that cannabis production and sales are done in a way that maximizes public health and safety. The Office of Cannabis Management, which is charged with issuing licenses for businesses to participate in New York's adult-use cannabis industry, has only issued a relatively small number of licenses.
The void has been filled by the proliferation of unlicensed businesses.
In many cases, confusion and misinformation regarding how the MRTA is intended to operate, coupled with a lack of practical enforcement measures in some parts of the state, have caused sellers and consumers to believe that they are engaging in legitimate cannabis transactions.
There are still restrictions in place which could carry a range of fines and penalties, even though the penalties for possession of cannabis and unauthorized sale are less severe. If you have more than three ounces of cannabis or twenty-four grams of concentrated cannabis, you could be fined up to $125, and if you have more than ten pounds of cannabis or four pounds of concentrated cannabis, you could be fined.
Penalties range from a fine of up to $250 to a class C felony for selling cannabis without a license. If you are caught smoking cannabis in a tobacco-free area, you could be fined up to $25 or 20 hours of community service.
Legislation has been proposed that would prevent businesses who engage in the unlicensed sale of cannabis from later obtaining a license and participating in the state's regulated industry. The ability to participate in the licensed and regulated adult-use cannabis market may be at risk for those who participate in the unlicensed grey market.
When buying cannabis products in the gray market, consumers don't know that the cannabis products they use and ingest are subject to stringent regulatory testing and labeling requirements contemplated by the MRTA. Unsafe products are more likely to find their way into the stream of commerce.
To ensure compliance with the applicable law, any individual or business interested in participating in the adult-use cannabis industry in New York should take the time to review and understand the MRTA.
Jonathan is a partner at Kaufman Dolowich & Voluck, where he focuses on liability litigation, insurance, and cannabis matters. Kaufman Dolowich & Voluck has an associate named Adam Nicolazzo who focuses on insurance coverage and commercial litigation matters.
Keywords: cannabis, broad market participation, the regulatory framework needed, Adult-use cannabis